Cost-effectiveness of rotavirus vaccination in Mozambique

Funding Information: The authors received funding from Bill and Melinda Gates Foundation (OPP1147721), through PATH subaward number: GAT.2111-01707508-SUB. Funding Information: We thank the EPI and the NITAG, from Mozambique for their support and commitment to the present analysis. We also thank PAT...

Full description

Bibliographic Details
Main Author: Lourenço Guimarães, Esperança (author)
Other Authors: Chissaque, Assucênio (author), Pecenka, Clint (author), Clark, Andrew (author), Vaz, Basília (author), Banze, Arlindo (author), Canana, Neide (author), Romão, Clésio (author), do Rosário Oliveira Martins, Maria (author), de Deus, Nilsa (author), Debellut, Frédéric (author)
Format: article
Language:eng
Published: 2022
Subjects:
Cost-effectiveness
Diarrhea
Modelling
Mozambique
Rotavirus
UNIVAC
Vaccination
Molecular Medicine
Immunology and Microbiology(all)
veterinary(all)
Public Health, Environmental and Occupational Health
Infectious Diseases
SDG 3 - Good Health and Well-being
Online Access:http://hdl.handle.net/10362/145718
Country:Portugal
Oai:oai:run.unl.pt:10362/145718
Description
Summary:Funding Information: The authors received funding from Bill and Melinda Gates Foundation (OPP1147721), through PATH subaward number: GAT.2111-01707508-SUB. Funding Information: We thank the EPI and the NITAG, from Mozambique for their support and commitment to the present analysis. We also thank PATH team for the technical support and Laura Kallen (from PATH) for linguistic revision of the manuscript. The authors received funding from Bill and Melinda Gates Foundation (OPP1147721), through PATH subaward number: GAT.2111-01707508-SUB. Publisher Copyright: © 2022 The Authors

Similar Items